As described above, clinical observation provided novel findings of lipodystrophy in a PRAAS patient (68), and a knock-in mouse model revealed the contribution of NLRP3-mutant hematopoietic cells to cartilage overgrowth (44). The gene discussed is NLRP3; the disease is lipodystrophy.